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Abstract: In this paper we investigate some stochastic models for tumor-
immune systems. To describe these models we used a Wiener process, as the
noise has a stabilization effect. Their dynamics are studied in terms of stochas-
tic stability in the equilibrium points, by constructing the Lyapunov exponent,
depending on the parameters that describe the model. We have studied and
analyzed a Kuznetsov-Taylor like stochastic model and a Bell stochastic model
for tumor-immune systems. These stochastic models are studied from stability
point of view and they were represented using the Euler second order scheme.
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1 Introduction
Cancer is a disease that may affect people at all ages. It causes about 13%
of all human deaths. In the prognosis of cancer patients, it should be taken into
consideration the type of cancer and the stage of the disease. Cancers may be
treated or cured, depending on the specific type, location, and stage. We may
say that surgery and chemotherapies play an important role in treating cancer,
but they do not represent a cure. What it is needed is a successful treatment
strategies, one of these strategies is investigated through immunotherapy [13],
by defining a model of differential equations that represents the interaction
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2between effector cells and tumor cells. This idea of immunotherapy is promis-
ing, but controversial from the point of view of the results obtained in medical
investigations.
Stochastic modelling plays an important role in many branches of science.
Because in practical situations we confront with instability and perturbations,
we will express our mathematical models using white noise, represented by
brownian motion. We will study stochastic dynamical systems that are used
in medicine, in describing a tumor behavior. Cancer tumor may be destroyed
using some treatments, but a regression of the disease may appear. So, we need
not only preventative measures, but also more successful treatment strategies.
Efforts along these lines are now being investigated through immunotherapy
([5], [20], [22]). A simulating model is described by the existence of tumor
free equilibrium. A tumor size may tend to +∞, depending on the parameters
of the model, and may exist a ”small tumor size” equilibrium, which coexists
with the tumor free equilibrium [10].
This tumor-immune study, from theoretical point of view, has been done for
two cell populations: effector cells and tumor cells. It was predicted a thresh-
old above which there is uncontrollable tumor growth, and below which the
disease is attenuated with periodic exacerbations occurring every 3-4 months.
There was also shown that the model does have stable spirals, but the Dulac-
Bendixson criterion demonstrates that there are no stable closed orbits. It is
consider ODE’s for the populations of immune and tumor cells and it is shown
that survival increases if the immune system is stimulated, but in some cases
an increase in effector cells increases the chance of tumor survival.
In the last years, stochastic growth models for cancer cells were developed.
These models simulate the way tumors evolve with respect to a certain therapy,
but also they show the interactions between tumor cells and immune cells. We
mention the papers of W.Y. Tan and C.W. Chen [19], N. Komarova, G. Albano
and V.Giorno [1], L. Ferrante, S. Bompadre, L. Possati and L. Leone [6], A.
Boondirek Y. Lenbury, J. Wong-Ekkabut, W. Triampo, I.M. Tang, P. Picha
[4].
Our goal in this paper is to construct stochastic models and to analyze
their behavior around the equilibrium point. In these points stability is stud-
ied by analyzing the Lyapunov exponent, depending of the parameters of the
models. Numerical simulations are done using a deterministic algorithm with
an ergodic invariant measure. In this paper, the authors studied and analyzed
two stochastic models. In Section 2, we considered a Kuznetsov and Taylor
stochastic model. Beginning from the classical one, we have studied the case
of positive immune response. We gave the stochastic model and we analyzed
3it in the equilibrium points. Numerical simulations for this new model are
presented in Section 2.1. In Section 3 we presented a general family of tumor-
immune stochastic systems and from this general representation, we analyzed
Bell model. We wrote this model as a stochastic model, using Annexe 1, and
we discussed its behavior around the equilibrium points. Numerical simula-
tions were done using the software Maple 12 and we implemented the second
order Euler scheme for a representation of the discussed stochastic models,
described in Annexe 2.
2 Kuznetsov and Taylor stochastic model
We will begin our study from the model of Kuznetsov and Taylor [13]. This
model describes the response of effector cells to the growth of tumor cells and
takes into consideration the penetration of tumor cells by effector cells, that
causes the interaction of effector cells. This model can be represented in the
following way: {
x˙(t) = a1 − a2x(t) + a3x(t)y(t),
y˙(t) = b1y(t)(1− b2y(t))− x(t)y(t), (1)
where initial conditions are x(0) = x0 > 0, y(0) = y0 > 0 and a3 is the immune
response to the appearance of the tumor cells.
In this paper we consider the case of a3 > 0, that means that immune re-
sponse is positive. For the equilibrium states P1 and P2, we study the asymp-
totic behavior with respect to the parameter a1 in (1). For b1a2 < a1, the
system (1) has the equilibrium states P1(x1, y1) and P2(x2, y2), with
x1 =
a1
a2
, y1 = 0, (2)
x2 = (b1(a3 − b2a2) +
√
∆)/(2a3), y2 = (b1(a3 + b2a2)−
√
∆/(2b1b2a3) (3)
where ∆ = b21(b2a2 − a3)2 + 4b1b2a1a3.
In [13] it is shown that there is an a10 such that if a1 < a10, the equilibrium
state P1 is asymptotical stable, for a1 > a10 the equilibrium state P1 is unstable
and if a1 < a10 the equilibrium state P2 is unstable and for a1 > a10 the
equilibrium state P2 is asymptotical stable.
In the following, we associate a stochastic system of differential equations
to the classical system of differential equations (1).
4Let us consider (Ω,Ft≥0,P) a filtered probability space and (W (t))t≥0 a
standard Wiener process adapted to the filtration (F)t≥0. Let {X(t) = (x(t), y(t))}t≥0
be a stochastic process.
The system of Itoˆ equations associated to system (1) is given by
x(t) = x0 +
∫ t
0
(a1 − a2x(s) + a3x(s)y(s))ds+
∫ t
0
g1(x(s), y(s))dW (s),
y(t) = y0 +
∫ t
0
((b1y(s)(1− b2y(s))− x(s)y(s))ds+
∫ t
0
g2(x(s), y(s))dW (s),
(4)
where the first integral is a Riemann integral, and the second one is an Itoˆ
integral. {W (t)}t≥0 is a Wiener process [16].
The functions g1(x(t), y(t)) and g2(x(t), y(t)) are given in the case when we
are working in the equilibrium state. In P1 those functions have the following
form
g1(x(t), y(t)) = b11x(t) + b12y(t) + c11,
g2(x(t), y(t)) = b21x(t) + b22y(t) + c21,
(5)
where
c11 = −b11x1 − b12y1, c21 = −b21x1 − b22y1. (6)
In the equilibrium state P2, the functions g1(x(t), y(t)) and g2(x(t), y(t))
are given by
g1(x(t), y(t)) = b11x(t) + b12y(t) + c12,
g2(x(t), y(t)) = b21x(t) + b22y(t) + c22,
(7)
where
c12 = −b11x2 − b12y2, c22 = −b21x2 − b22y2. (8)
The functions g1(x(t), y(t)) and g2(x(t), y(t)) represent the volatilisations
of the stochastic equations and they are the therapy test functions.
2.1 The analysis of SDE (4). Numerical simulation.
Using the formulae from Annexe 1, Annexe 2, and Maple 12 software,
we get the following results, illustrated in the figures below. For numerical
simulations, we use the following values for the parameters of the system (4):
a1 = 0.1181, a2 = 0.3747, a3 = 0.01184, b1 = 1.636, b2 = 0.002.
5The matrices A and B are given, in the equilibrium point P1(
a1
a2
, 0) by
A =
(−a2 + a3y1 a3x1
−y1 b1 − 2b2y1 − x1
)
, B =
(
10 −2
2 10
)
.
In a similar way, matrices A and B are defined in the other equilibrium
point
P2
((−b1(b2a2 − a3) +√∆)
2a3
,
(b1(b2a2 + a3)−
√
∆)
2b1b2a3
)
,
with ∆ = b21(b2a2 − a3)2 + 4b1b2a1a3.
Using the second order Euler scheme for the ODE system (1), respectively
SDE system (4), we get the following orbits.
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The Lyapunov exponent, for the equilibrium point P1 is negative, so P1
is asymptotically stable for each α ∈ R. For the equilibrium point P2, it is
asymptotically stable for all values of α from the interval (−1.8, 1.8), that
means that P2 is unstable for all α ∈ (−∞,−1.8) ∪ (1.8,∞).
3 A general family of tumor-immune stochas-
tic systems
A Volterra-like model was proposed in [17], for the interaction between a
population of tumor cells (whose number is denoted by x) and a population
8of lymphocyte cells (y), and it is given by
{
x˙(t) = ax(t)− bx(t)y(t),
y˙(t) = dx(t)y(t)− fy(t)− kx(t), (9)
where the tumor cells are supposed to be in exponential growth (which is, how-
ever, a good approximation only for the initial phases of the growth) and the
presence of tumor cells implies a decrease of the ”input rate” of lymphocytes.
A general representation for such models can be considered in the form
given by d’Onofrio in [5]:
{
x˙(t) = f1(x(t), y(t)), y˙(t) = f2(x(t), y(t)),
x(0) = x0, y(0) = y0,
(10)
where x is the number of tumor cells, y the number of effector cells of immune
system and
f1(x(t), y(t)) = x(t)(h1(x(t))− h2(x(t))y(t)),
f2(x(t), y(t)) = (h3(x(t))− h4(x(t)))y(t) + h5(x(t)).
(11)
The functions h1, h2, h3, h4, h5 are given such that the system (10) admits the
equilibrium points P1(x1, y1), with x1 = 0, y1 > 0, and P2(x2, y2), with x2 6=
0, y2 > 0.
Particular cases, that will be discussed here, are the following:
Volterra model [21] if h1(x(t)) = a1, h2(x(t)) = a2x(t), h3(x(t)) = b3x(t), h4(x(t)) =
b2 and h5(x(t)) = −b1x(t);
Bell model [3] h1(x(t)) = a1x(t), h2(x(t)) = a2x(t), h3(x(t)) = b1x(t), h4(x(t)) =
b3 and h5(x(t)) = −b2x(t) + b4;
Stepanova model [18] with h1(x(t)) = a1, h2(x(t)) = 1, h3(x(t)) = b1x(t), h4(x(t)) =
b and h5(x(t)) = −b2x(t) + b4;
Vladar-Gonzalez model [20] if in (10) we consider h1(x(t)) = log(K/x(t)), h2(x(t)) =
1, h3(x(t)) = b1x(t), h4(x(t)) = b2 + b3x
2(t) and h5(x(t)) = 1;
Exponential model [22] if in (10) we consider h1(x(t)) = 1, h2(x(t)) = 1,
h3(x(t)) = b1x(t), h4(x(t)) = b2 + b3x
2(t), and h5(x(t)) = 1;
Logistic model [14] if in (10) we consider h1(x(t)) = 1− a1x(t) , h2(x(t)) = 1,
h3(x(t)) = b1x(t), h4(x(t)) = b2 + b3x
2(t), and h5(x(t)) = 1.
9For a considered filtered probability space (Ω,Ft≥0,P) and a standard
Wiener process (W (t))t≥0, we consider the stochastic process in two dimen-
sional space (F)t≥0.
The system of Itoˆ equations associated to system (10) is given, in the
equilibrium point P (x0, y0), by
x(t) = x0 +
∫ t
0
[x(s)(h1(x(s))− h2(x(s))y(s)]ds+
∫ t
0
g1(x(s), y(s))dW (s),
y(t) = y0 +
∫ t
0
[(h3(x(s))− h4(x(s)))y(s) + h5(x(s))]ds+
+
∫ t
0
g2(x(s), y(s))dW (s),
(12)
where the first integral is a Riemann integral, and the second one is an Itoˆ
integral. {W (t)}t≥0 is a Wiener process [16].
The functions g1(x(t), y(t)) and g2(x(t), y(t)) are given in the case when we
are working in the equilibrium state Pe, and they are given by
g1(x(t), y(t)) = b11x(t) + b12y(t) + c1e,
g2(x(t), y(t)) = b21x(t) + b22y(t) + c2e,
(13)
where
cie = −bi1xe − bi2ye, i = 1, 2, (14)
and bij ∈ R, i, j = 1, 2.
3.1 Analysis of Bell model. Numerical simulations.
Following the algorithm for determining the Lyapunov exponent (A1) and
the description of the second order Euler scheme (A2) in Maple 12 software,
we get the following results, illustrated in the figures below. For numerical
simulations we use the following values of parameters:
a1 = 2.5, a2 = 1, b1 = 1, b2 = 0.4, b3 = 0.95, b4 = 2.
The matrices A and B are given, in the equilibrium point P1 by
A =
(−a2y1 + a1 −a2x1
−b2 + b1y1 b1x1 − b3
)
, B =
(
α −β
β α
)
,
with α = a ∈ R, β = −2. In a similar way the matrices A and B are defined
in the equilibrium point P2
(
a1b3−a2b4
a1b1−a2b2
, a1
a2
)
.
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The Lyapunov exponent variation, with b11 = α a variable parameter,
is given in Figure 27 for the equilibrium point P1, and in Figure 28 for the
equilibrium point P2.
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Fig 27: (α, λ(α)) in P1 Fig 28: (α, λ(α)) in P2
From the figures above, the equilibrium points P1 and P2 are asymptotically
stable for all α such that the Lyapunov exponents λ(α) < 0, and unstable
otherwise. So, P1 is asymptotically stable for α ∈ (−∞,−1.78) ∪ (2.02,∞)
and P2 is asymptotically stable for α ∈ (−∞,−1.62) ∪ (1.88,∞).
4 Conclusions
As considered in this paper, we used established conceptual models, but it
is also very important to consider the model through all its aspects, as we have
done in this case by imposing the positivity of its solutions. Even if the initial
model violates the positivity rule, it is valuable because it may be read as a
model which takes into account a disease-induced depression in the influx of
lymphocytes. Then, instead of proposing another specific model, we preferred
to add this new feature to a family of equations, and so, in particular to our
models chosen for study.
We have focused on two important tumor-immune systems, presented from
stochastic point of view: a Kuznetsov-Taylor model and Bell model, that be-
longs to a general family of tumor-immune stochastic systems. We have deter-
mined the equilibrium points and we have calculated the Lyapunov exponents.
A computable algorithm is presented in A1. These exponents help us to decide
whether the stochastic model is stable or not. For numerical simulations we
13
have used the Euler scheme presented in detail in A2 and the implementation
of this algorithm was done in Maple 12. In a similar way other models given by
(11) can be studied. The model given by the SDE (12) allows the control of the
model given by ODE (1) with a stochastic process. This model is dependent
on initial conditions. These are very difficult to find for a concrete case, that
is why it is quite impossible to plan an anticancer therapy based only on this
method. This is the ony disadvantage for the immunotherapy.
In our further work, we will consider the tumor-immune model with delay,
and also another technique used for a successful therapy, using synchronization
of the coupled tumor-immune model of repressilators in tumor cells aggrega-
tions.
Annexe
A1 Lyapunov exponents and stability in stochastic 2-
dimensional structures.
The behavior of a deterministic dynamical system which is disturbed by
noise may be modelled by a stochastic differential equation (SDE). In many
practical situations, perturbations are generated by wind, rough surfaces or
turbulent layers are expressed in terms of white noise, modelled by brownian
motion. The stochastic stability has been introduced by Bertram and Sarachik
[12] and is characterized by the negativeness of Lyapunov exponents. But it
is not possible to determine this exponents explicitly. Many numerical ap-
proaches have been proposed, which generally used simulations of stochastic
trajectories.
Let (Ω,F,P) a probability space. It is assumed that the σ−algebra Ft(t ≥
0) such that
Fs ⊂ Ft ⊂ F, ∀ s ≤ t, s, t ∈ I,
where I = [0, T ], T ∈ (0,∞).
Let {x(t) = (x1(t), x2(t))}t≥0 be a stochastic process. The system of Itoˆ
equations
dxi(t, ω) = fi(x(t, ω))dt+ gi(x(t, ω))dW (t, ω), i = 1, 2, (15)
with initial condition x(0) = x0 is interpreted in the sense that
xi(t, ω) = xi0(t, ω)+
∫ t
0
fi(x(s, ω))ds+
∫ t
0
gi(x(s, ω))dW (s, ω), i = 1, 2, (16)
14
for almost all ω ∈ Ω and for each t > 0, where fi(x) is a drift function,
gi(x) is a diffusion function,
∫ t
0
fi(x(s))ds, i = 1, 2 is a Riemann integral and∫ t
0
gi(x(s))dW (s), i = 1, 2 is an Itoˆ integral. It is assumed that fi and gi, i =
1, 2 satisfy the conditions of existence of solutions for this SDE with initial
conditions x(0) = a0 ∈ Rn.
Let x0 = (x01, x02) ∈ R2 be a solution of the system
fi(x0) = 0, i = 1, 2. (17)
The functions gi are chosen such that
gi(x0) = 0, i = 1, 2.
In the following, we will consider
gi(x) =
2∑
j=1
bij(xj − x0j), i = 1, 2, (18)
where bij ∈ R, i = 1, 2.
The liniarized of system (16) in x0 is given by
X(t) =
∫ t
0
AX(s)ds+
∫ t
0
BX(s)dW (s), (19)
where
X(t) =
[
x(t, ω)
y(t, ω)
]
, A =
[
a11 a12
a21 a22
]
, B =
[
b11 b12
b21 b22
]
(20)
aij =
∂fi
∂xj
∣∣∣
x0
, bij =
∂gi
∂xj
∣∣∣
x0
. (21)
The Oseledec multiplicative ergodic theorem [15] asserts the existence of
two non-random Lyapunov exponents λ2 ≤ λ1 = λ. The top Lyapunov expo-
nent is given by
λ = lim
t→∞
1
t
sup log
√
x(t)2 + y(t)2. (22)
Applying the change of coordinates
x(t) = r(t) cos θ(t), x(t) = r(t) sin θ(t),
by writing the Itoˆ formula for
h1(x, y) =
1
2
log(x2 + y2) = log(r),
h2(x, y) = arctan
(y
x
)
,
results
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Proposition 1
log
( r(t)
r(0)
)
=
∫ t
0
q1(θ(s)) +
1
2
(q4(θ(s))
2 − q2(θ(s))2)ds+
∫ t
0
q2(θ(s))dW (s),
(23)
θ(t) = θ(0) +
∫ t
0
(q3(θ(s))− q2(θ(s))q4(θ(s)))ds+
∫ t
0
q4(θ(s))dW (s), (24)
where
q1(θ) = a11 cos
2 θ + (a12 + a21) cos θ sin θ + a22 sin
2 θ,
q2(θ) = b11 cos
2 θ + (b12 + b21) cos θ sin θ + b22 sin
2 θ,
q3(θ) = a21 cos
2 θ + (a22 − a11) cos θ sin θ − a12 sin2 θ,
q4(θ) = b21 cos
2 θ + (b22 − b11) cos θ sin θ − b12 sin2 θ.
(25)
As the expectation of the Itoˆ stochastic integral is null,
E
∫ t
0
q2(θ(s))dW (s) = 0,
the Lyapunov exponent is given by
λ = lim
t→∞
1
t
log
( r(t)
r(0)
)
= lim
t→∞
1
t
E
∫ t
0
[q1(θ(s)) +
1
2
(q4(θ(s))
2 − q2(θ(s)))]ds.
Applying the Oseledec theorem, if r(t) is ergodic, results that
λ =
∫ t
0
[q1(θ) +
1
2
(q4(θ)
2 − q2(θ))]p(θ)dθ, (26)
where p(θ) is the probability distribution of the process θ. ✷
An approximation of this distribution is calculated by solving the Fokker-
Planck equation. Associated with equation (24) for p = p(t, θ) we get
∂p
∂t
+
∂
∂θ
(q3(θ)− q2(θ)q4(θ)p)− 1
2
∂2
∂θ2
(q4(θ)
2p) = 0. (27)
From (27) results that the solution p(θ) of the Fokker-Planck equation is
the solution of the following first order equation
(−q3(θ) + q1(θ)q4(θ) + q2(θ)q5(θ))p(θ) + 1
2
q4(θ)
2p′(θ) = p0, (28)
where p′(θ) = dp
dθ
and
q5(θ) = −(b12 + b21) sin 2θ − (b22 − b11) cos 2θ. (29)
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Proposition 2 If q4(θ) 6= 0, the solution of equation (28) is given by
p(θ) =
K
D(θ)q4(θ)2
(1 + η
∫ θ
0
D(u)du), (30)
where K is determined by the normality condition
∫ 2pi
0
p(θ)dθ = 1, (31)
and
η =
D(2π)− 1∫ 2pi
0
D(u)du
. (32)
The function D is given by
D(θ) = exp
(
− 2
∫ θ
0
q3(u)− q2(u)q4(u)− q4(u)q5(u)
q4(u)2
du
)
. (33)
✷
A numerical solution of the phase distribution could be performed by a
simple backward difference scheme.
Let N ∈ R+ and h = piN . Let
q1(i) = a11 cos
2(ih) + (a12 + a21) cos(ih) sin(ih) + a22 sin
2(ih),
q2(i) = b11 cos
2(ih) + (b12 + b21) cos(ih) sin(ih) + b22 sin
2(ih),
q3(i) = a21 cos
2(ih) + (a22 − a11) cos(ih) sin(ih)− a12 sin2(ih),
q4(i) = b21 cos
2(ih) + (b22 − b11) cos(ih) sin(ih)− b12 sin2(ih),
q5(i) = −(b12 + b21) sin(2ih)− (b22 − b11) cos(2ih).
(34)
The p(i), i = 0, ..., N is given by the following relations
p(i) = (p(0) +
q4(i)
2p(i− 1)
2h
)F (i),
where
F (i) =
2h
2h(−q3(i) + q2(i)q4(i) + q4(i)q5(i)) + q4(i)2 .
The Lyapunov function is λ = λ(N), where
λ(N) =
N∑
i=1
(q1(i) +
1
2
(q4(i)
2 − q2(i)2))p(i)h.
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Proposition 3 If the matrix B is given by
b11 = α, b12 = −β, b21 = β, b22 = α,
probability distribution p(θ) is given by
p(θ) =
K
β2
exp{ 1
β2
((a21−a12−αβ)θ+ 1
2
(a11−a22) cos 2θ+ 1
2
(a21−a12) sin 2θ},
K =
β2∫ 2pi
0
exp{ 1
β2
((a21 − a12 − αβ)θ + 12(a11 − a22) cos 2θ + 12(a21 − a12) sin 2θ}
dθ,
and the Lyapunov exponent is given by
λ =
1
2
(a11 + a22 + β
2 − α2) + 1
2
(a11 − a22)c2 + 1
2
(a21 + a12)s2,
where
c2 =
2pi∫
0
cos(2θ)p(θ)dθ, s2 =
2pi∫
0
sin(2θ)p(θ)dθ.
✷
A2 The Euler scheme.
In general 2-dimensional case, the Euler scheme has the form:
xi(n + 1) = xi(n) + fi(x(n))h+ gi(x(n))Gi(n), i = 1, 2, (35)
with Wiener process increment
Gi(n) = Wi((n+ 1)h)−Wi(nh), n = 0, ..., N − 1, i = 1, 2,
and ξ(n) = ξ(nh, ω), Gi(n) are generated using boxmuller method.
It is shown that Euler scheme has the order for weak convergence 1, for
sufficiently regular drift and diffusion coefficients.
We assume that fi and gi in (35) are sufficiently smooth such that the
following schemas are well defined.
The second order Euler scheme is defined by the relations
xi(n+ 1) = xi(n) + fi(x(n))h + gi(x(n))Gi(n) + gi(x(n))
∂
∂xi(n)
gi(x(n))
Gi(n)
2 − h
2
+
+
[
fi(x(n))
∂fi(x(n))
∂xi(n)
+
1
2
(gi(x(n))
2 ∂
2fi(x(n))
∂xi(n)∂xi(n)
]h2
2
+
[
gi(x(n))
∂fi(x(n))
∂xi(n)
+ fi(x(n))
∂gi(x(n))
∂xi(n)
+
1
2
(gi(x(n))
2 ∂
2gi(x(n))
∂xi(n)∂xi(n)
]hGi(n)
2
, i = 1, 2,
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where we used the random variables Gi(n), i = 1, 2. In [11], it is shown that
these schemes converge weakly with order 2.
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